Pharmacological interventions such as orlistat or GLP-1 receptor agonists may be considered for patients with BMI 30 kg/m who have not achieved adequate weight loss through lifestyle measures alone
About the Compounds BPC-157 a synthetic 15-amino-acid peptide (pentadecapeptide) derived from a protein found in human gastric juice
That lack of approval matters
In addition, intranasal administration offers the potential advantages of a more rapid onset of action and avoidance of first-pass metabolism [28]
The most common side effects are gastrointestinal, including nausea (occurring in 20-30% of patients), diarrhea, vomiting, constipation, and abdominal discomfort
Given side effects like nausea, a man with normal erectile function is unlikely to find the trade-off worthwhile